News

Published on 16 May 2023 on Simply Wall St. via Yahoo Finance

Exagen (NASDAQ:XGN) shareholders are up 20% this past week, but still in the red over the last three...


Article preview image

Exagen Inc. (NASDAQ:XGN) shareholders will doubtless be very grateful to see the share price up 43% in the last month. But only the myopic could ignore the astounding decline over three years. To wit, the share price sky-dived 73% in that time. So it's about time shareholders saw some gains. Of course the real question is whether the business can sustain a turnaround.

While the last three years has been tough for Exagen shareholders, this past week has shown signs of promise. So let's look at the longer term fundamentals and see if they've been the driver of the negative returns.

View our latest analysis for Exagen

NASDAQ.XGN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect

Exagen Inc (NASDAQ:XGN) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus...

GuruFocus.com · via Yahoo Finance 11 Nov 2024

Analyst Estimates: Here's What Brokers Think Of Exagen Inc. (NASDAQ:XGN) After Its Annual Report

A week ago, Exagen Inc. (NASDAQ:XGN) came out with a strong set of annual numbers that could pote...

Simply Wall St. via Yahoo Finance 21 Mar 2024

Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript

Exagen Inc. (NASDAQ:XGN) Q4 2023 Earnings Call Transcript March 18, 2024 Exagen Inc.  isn't one o...

Insider Monkey via Yahoo Finance 20 Mar 2024

Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Es...

Zacks via Yahoo Finance 19 Mar 2024

Zynex Inc. (ZYXI) Q4 Earnings and Revenues Miss Estimates

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensu...

Zacks via Yahoo Finance 29 Feb 2024

Despite Fast-paced Momentum, Exagen Inc. (XGN) Is Still a Bargain Stock

Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy ...

Zacks via Yahoo Finance 7 Feb 2024

Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates

Exagen Inc. (XGN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Es...

Zacks via Yahoo Finance 8 Aug 2023

This Exagen Insider Increased Their Holding In The Last Year

From what we can see, insiders were net buyers in Exagen Inc.'s (NASDAQ:XGN ) during the past 12 ...

Simply Wall St. via Yahoo Finance 24 Jul 2023

Exagen Inc.'s (NASDAQ:XGN) Low P/S No Reason For Excitement

With a price-to-sales (or "P/S") ratio of 1.2x Exagen Inc. (NASDAQ:XGN) may be sending very bulli...

Simply Wall St. via Yahoo Finance 13 Jun 2023

Exagen (NASDAQ:XGN) shareholders are up 20% this past week, but still in the red over the last three...

Exagen Inc. (NASDAQ:XGN) shareholders will doubtless be very grateful to see the share price up 4...

Simply Wall St. via Yahoo Finance 16 May 2023